Yang H - Search Results

1

Dosage optimization for reducing tumor burden using a phenotype-structured population model with a drug-resistance continuum.

Han L, Yogurtcu ON, Rodriguez Messan M, Valega-Mackenzie W, Nukala U, Yang H. Han L, et al. Among authors: yang h. Math Med Biol. 2024 Mar 15;41(1):35-52. doi: 10.1093/imammb/dqae003. Math Med Biol. 2024. PMID: 38408192

2

Predictive model for Zika virus RNA minipool nucleic acid testing in outbreak scenarios.

Yogurtcu ON, Yang H, Chancey C, Forshee RA, Eder AF. Yogurtcu ON, et al. Among authors: yang h. Transfusion. 2019 Jul;59(7):2211-2217. doi: 10.1111/trf.15296. Epub 2019 Apr 2. Transfusion. 2019. PMID: 30938839

3

TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity.

Yogurtcu ON, Sauna ZE, McGill JR, Tegenge MA, Yang H. Yogurtcu ON, et al. Among authors: yang h. AAPS J. 2019 Aug 2;21(5):96. doi: 10.1208/s12248-019-0368-0. AAPS J. 2019. PMID: 31376048

4

SampPick: Selection of a Cohort of Subjects Matching a Population HLA Distribution.

McGill JR, Yogurtcu ON, Verthelyi D, Yang H, Sauna ZE. McGill JR, et al. Among authors: yang h. Front Immunol. 2019 Dec 20;10:2894. doi: 10.3389/fimmu.2019.02894. eCollection 2019. Front Immunol. 2019. PMID: 31921155 Free PMC article.

5

A Quantitative Evaluation of COVID-19 Epidemiological Models.

Yogurtcu ON, Messan MR, Gerkin RC, Belov AA, Yang H, Forshee RA, Chow CC. Yogurtcu ON, et al. Among authors: yang h. medRxiv [Preprint]. 2021 Feb 8:2021.02.06.21251276. doi: 10.1101/2021.02.06.21251276. medRxiv. 2021. PMID: 33564783 Free PMC article. Preprint.

6

A Systematic Review of the Efforts and Hindrances of Modeling and Simulation of CAR T-cell Therapy.

Nukala U, Rodriguez Messan M, Yogurtcu ON, Wang X, Yang H. Nukala U, et al. Among authors: yang h. AAPS J. 2021 Apr 9;23(3):52. doi: 10.1208/s12248-021-00579-9. AAPS J. 2021. PMID: 33835308

7

Mathematical model of a personalized neoantigen cancer vaccine and the human immune system.

Rodriguez Messan M, Yogurtcu ON, McGill JR, Nukala U, Sauna ZE, Yang H. Rodriguez Messan M, et al. Among authors: yang h. PLoS Comput Biol. 2021 Sep 24;17(9):e1009318. doi: 10.1371/journal.pcbi.1009318. eCollection 2021 Sep. PLoS Comput Biol. 2021. PMID: 34559809 Free PMC article.

8

Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years.

Funk PR, Yogurtcu ON, Forshee RA, Anderson SA, Marks PW, Yang H. Funk PR, et al. Among authors: yang h. Vaccine. 2022 Apr 26;40(19):2781-2789. doi: 10.1016/j.vaccine.2022.03.030. Epub 2022 Mar 28. Vaccine. 2022. PMID: 35370016 Free PMC article.

9

Analysis of tumor-immune functional responses in a mathematical model of neoantigen cancer vaccines.

Han L, Rodriguez Messan M, Yogurtcu ON, Nukala U, Yang H. Han L, et al. Among authors: yang h. Math Biosci. 2023 Feb;356:108966. doi: 10.1016/j.mbs.2023.108966. Epub 2023 Jan 13. Math Biosci. 2023. PMID: 36642160

10

A Retrospective Review of Center for Biologics Evaluation and Research Advisory Committee Meetings in the Context of the FDA's Benefit-Risk Framework.

Mutanga JN, Nukala U, Rodriguez Messan M, Yogurtcu ON, McCormick Q, Sauna ZE, Whitaker BI, Forshee RA, Yang H. Mutanga JN, et al. Among authors: yang h. AAPS J. 2023 Feb 9;25(1):24. doi: 10.1208/s12248-023-00789-3. AAPS J. 2023. PMID: 36759415 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,403 results

Search Page

Filters